Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JAK3 Is Expressed in the Nucleus of Malignant T Cells in Cutaneous T Cell Lymphoma (CTCL)
Chella Krishna Vadivel, Maria Gluud, Sara Torres‐Rusillo, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 280-280
Open Access | Times Cited: 21

Showing 21 citing articles:

JAK-STAT signaling in inflammation and stress-related diseases: implications for therapeutic interventions
Alexey Sarapultsev, Evgeni Gusev, Maria Komelkova, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 64
Staphylococcus aureus induces drug resistance in cancer T cells in Sézary syndrome
Chella Krishna Vadivel, Andreas Willerslev-Olsen, Martin R. J. Namini, et al.
Blood (2024) Vol. 143, Iss. 15, pp. 1496-1512
Open Access | Times Cited: 16
JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe? A Systematic Review of the Published Literature
Seyed Mohammad Vahabi, Saeed Bahramian, Farzad Esmaeili, et al.
Cancers (2024) Vol. 16, Iss. 5, pp. 861-861
Open Access | Times Cited: 9
Molecular pathogenesis of Cutaneous T cell Lymphoma: Role of chemokines, cytokines, and dysregulated signaling pathways
Kalyani Patil, Shilpa Kuttikrishnan, Abdul Quaiyoom Khan, et al.
Seminars in Cancer Biology (2021) Vol. 86, pp. 382-399
Open Access | Times Cited: 42
Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency
Clifford Liongue, Tarindhi Ratnayake, Faiza Basheer, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2977-2977
Open Access | Times Cited: 6
The Role of Cytokines in Cutaneous T Cell Lymphoma: A Focus on the State of the Art and Possible Therapeutic Targets
Alba Guglielmo, Corrado Zengarini, Claudio Agostinelli, et al.
Cells (2024) Vol. 13, Iss. 7, pp. 584-584
Open Access | Times Cited: 4
Safety and Danger Considerations of Novel Treatments for Atopic Dermatitis in Context of Primary Cutaneous Lymphomas
Karol Kołkowski, Magdalena Trzeciak, Małgorzata Sokołowska‐Wojdyło
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13388-13388
Open Access | Times Cited: 24
Landscape of Genetic Mutations in Appendiceal Cancers
Marian Constantin, Cristina Mătanie, Livia Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3591-3591
Open Access | Times Cited: 6
Impaired Vitamin D Signaling in T Cells From a Family With Hereditary Vitamin D Resistant Rickets
Fatima A. H. Al-Jaberi, Martin Kongsbak, Alejandro Aguayo‐Orozco, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 13
Genomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an N-of-1 clinical trial
Montaser Shaheen, Julie Y. Tse, Ethan Sokol, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 10
A case of erythrodermic mycosis fungoides responding to upadacitinib
David Castillo, Paolo Romanelli, Hadar Lev‐Tov, et al.
JAAD Case Reports (2022) Vol. 30, pp. 91-93
Open Access | Times Cited: 7
Immunohistochemical Expression Patterns of CD45RO, p105/p50, JAK3, TOX, and IL-17 in Early-Stage Mycosis Fungoides
Tariq N. Aladily, Tasnim Abushunar, Ahmad Alhesa, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 220-220
Open Access | Times Cited: 5
Clinical Guidelines and New Molecular Targets for Cutaneous Lymphomas
Makoto Sugaya
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11079-11079
Open Access | Times Cited: 6
Janus Kinase Signaling: Oncogenic Criminal of Lymphoid Cancers
Boheng Li, Qin Wan, Zhubo Li, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5147-5147
Open Access | Times Cited: 5
Evaluation of coumarin and their derivatives as Janus Kinase-3 inhibitors using a theoretical model
Figueroa‐Valverde Lauro, López‐Ramos Maria, Magdalena Alvarez-Ramirez, et al.
Brazilian Journal of Science (2023) Vol. 2, Iss. 12, pp. 106-117
Open Access | Times Cited: 1
Immunolocalization and Expression of JAK1 and JAK3 in the Skin of Dust Mite-Sensitive Beagle Dogs before and after Allergen Exposure
Roberta Sartori, Kim Ahrens, Rachel Wilkes, et al.
Veterinary Sciences (2023) Vol. 10, Iss. 8, pp. 512-512
Open Access | Times Cited: 1
Dependence of peripheral T‐cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach
Kang Le, J Vollenweider, Jingjing Han, et al.
Hematological Oncology (2023) Vol. 42, Iss. 1
Closed Access | Times Cited: 1
Coupling of Some Carbazole Analogs with 3pjc Protein Surface as JAK3 Inhibitors
Lauro Figueroa-Valverde, Rosas‐Nexticapa Marcela, Catalina Cervantes-Ortega, et al.
Clinical Cancer Investigation Journal (2024) Vol. 13, Iss. 4, pp. 7-14
Closed Access
Proteomic profiling identifies classic Hodgkin lymphoma patients at risk of bleomycin pulmonary toxicity
Maja Dam Andersen, Katharina Wolter, Marie Beck Enemark, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-12
Open Access
Design and Molecular Dynamics Simulation of Thieno-pyrimidine derivative JAK3 Inhibitor
Poowadon Fukasem, M. Paul Gleeson
(2023), pp. 1-5
Closed Access
Genomic Landscape of Lymphatic Malformations: A Case Series and Response to the PI3Kα Inhibitor Alpelisib in an N-of-One Clinical Trial
Montaser Shaheen, Julie Y. Tse, Ethan Sokol, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top